Terminated PHASE4 INTERVENTIONAL 2-arm NCT01534286

A Randomized Double-Blind Placebo Controlled Trial to Determine the Status of Post Knee Chondroplasty Patients Administered Theramine Versus Placebo in Addition to Post Surgery Analgesics

Sponsor: Targeted Medical Pharma

Interventions Theramine Theramine- like placebo

Updated 6 times since 2017 Last updated: May 4, 2016 Started: Aug 31, 2012 Primary completion: Dec 31, 2013 Completion: Dec 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to recruit patients

Other terminated trials from Targeted Medical Pharma

Migraine Headaches · Phase PHASE4 · Oct 2015

More terminations from Targeted Medical Pharma

Listed as NCT01534286, this PHASE4 trial focuses on Knee Chondroplasty and Knee Pain and remains terminated or withdrawn. Sponsored by Targeted Medical Pharma, it has been updated 6 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE4
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE4
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE4
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE4
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Terminated PHASE4

First recorded

Aug 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Targeted Medical Pharma

Data source: Targeted Medical Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Gulf Breeze, United States